LY3461767

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3461767, covering 2024-05-30 to 2024-05-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection Fraction [Phase 1]